Drug Information Update- FDA approves new treatment for advanced pancreatic cancer

Drug Information Update- FDA approves new treatment for advanced pancreatic cancer FDA Division of Drug Information: Know the Moment It Happens The Division of Drug Information (DDI) is CDER’s focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA. The U.S. Food andContinue reading “Drug Information Update- FDA approves new treatment for advanced pancreatic cancer”

Irinotecan liposome injection

Irinotecan liposome injection FDA approved irinotecan liposome injection (ONIVYDE, Merrimack Pharmaceuticals, Inc.), administered in combination with fluorouracil (5FU) and leucovorin (LV), for the treatment ofpatients with metastatic adenocarcinoma of the pancreas whose disease has progressed following gemcitabine-based therapy. October 22, 2015. More Information: http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm468728.htm FDA Logo